These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 1069819)
21. The effect of smoking on influenza, influenza vaccination efficacy and on the antibody response to influenza vaccination. Cruijff M; Thijs C; Govaert T; Aretz K; Dinant GJ; Knottnerus A Vaccine; 1999 Feb; 17(5):426-32. PubMed ID: 10073719 [TBL] [Abstract][Full Text] [Related]
22. A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination. White WG; Freestone DS; Bowker CH; Barnes GM; Letley E; Ferris RD Dev Biol Stand; 1976; 33():202-6. PubMed ID: 782970 [TBL] [Abstract][Full Text] [Related]
23. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season. Pyhälä R; Ikonen N; Santanen R; Haanpää M; Visakorpi R; Jäppinen P; Valle M J Med Virol; 2001 Nov; 65(3):584-9. PubMed ID: 11596097 [TBL] [Abstract][Full Text] [Related]
24. Alice strain live attenuated influenza (H3N2) vaccin in an elderly population. Miller LW; Hume EB; O'Brien FR; Togo Y; Hornick RB Am J Epidemiol; 1975 Apr; 101(4):340-6. PubMed ID: 1168413 [TBL] [Abstract][Full Text] [Related]
25. Influenza vaccination with live-attenuated and inactivated virus-vaccines during an outbreak of disease. Rocchi G; Ragona G; Piga C; Pelosio A; Volpi A; Vella S; Legniti N; de Felici A J Hyg (Lond); 1979 Dec; 83(3):383-90. PubMed ID: 512351 [TBL] [Abstract][Full Text] [Related]
26. [Effect of multiple vaccination against influenza on the specificity of humoral immunity]. Iagodovskiĭ VV; Slepushkin AN; Schastnyĭ EI; Fedorova GI Vopr Virusol; 1986; 31(3):300-3. PubMed ID: 3765556 [TBL] [Abstract][Full Text] [Related]
27. Live attenuated influenza virus vaccine trial in children. Hall CB; Douglas G; Fralonardo SA Pediatrics; 1975 Dec; 56(6):991-8. PubMed ID: 1196767 [TBL] [Abstract][Full Text] [Related]
28. Natural challenge of subjects vaccinated with WRL 105 strain live influenza vaccine in a residential community. Morris CA; Freestone DS; Stealey VM Dev Biol Stand; 1976; 33():197-201. PubMed ID: 782969 [TBL] [Abstract][Full Text] [Related]
29. [The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains]. Kiseleva IV; Grigor'eva EP; Naĭkhin AN; Ivanova VV; Larionova NV; Donina SA; Litvinova OM; Aleksandrova GI; Rudenko LG Vopr Virusol; 2003; 48(4):26-9. PubMed ID: 12945203 [TBL] [Abstract][Full Text] [Related]
30. Protection by a polyvalent influenza vaccine and persistence of homologous and heterologous HI antibodies during a period of two epidemic seasons. Pyhälä R J Hyg (Lond); 1980 Apr; 84(2):237-45. PubMed ID: 7358963 [TBL] [Abstract][Full Text] [Related]
31. A trial of live virus intra-nasal influenza vaccine. Dodge JS N Z Med J; 1978 Feb; 87(605):79-82. PubMed ID: 273801 [TBL] [Abstract][Full Text] [Related]
32. [Seroconversion after vaccine with trivalent influenza vaccine during the epidemic season 1990/1 in Poland]. Brydak L; Rudnicka H; Gut W; Magdzik W; Kańtoch M Przegl Epidemiol; 1992; 46(3):221-9. PubMed ID: 1296247 [TBL] [Abstract][Full Text] [Related]
33. Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio. Strindhall J; Ernerudh J; Mörner A; Waalen K; Löfgren S; Matussek A; Bengner M Infect Dis (Lond); 2016; 48(6):436-42. PubMed ID: 27030916 [TBL] [Abstract][Full Text] [Related]
35. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. de Jong JC; Beyer WE; Palache AM; Rimmelzwaan GF; Osterhaus AD J Med Virol; 2000 May; 61(1):94-9. PubMed ID: 10745239 [TBL] [Abstract][Full Text] [Related]
36. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection. Goodeve A; Potter CW; Clark A; Jennings R; Schild GC; Yetts R J Hyg (Lond); 1983 Feb; 90(1):107-15. PubMed ID: 6822725 [TBL] [Abstract][Full Text] [Related]
37. The efficacy of live and inactivated vaccines of Hong Kong influenza virus in an industrial community. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines. Hobson D; Baker FA; Curry RL; Beare AS; Massey PM J Hyg (Lond); 1973 Dec; 71(4):641-7. PubMed ID: 4588772 [TBL] [Abstract][Full Text] [Related]
38. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines. Isakova-Sivak I; Rudenko L Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975 [TBL] [Abstract][Full Text] [Related]
39. Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial. Stephenson I; Nicholson KG; Glück R; Mischler R; Newman RW; Palache AM; Verlander NQ; Warburton F; Wood JM; Zambon MC Lancet; 2003 Dec; 362(9400):1959-66. PubMed ID: 14683655 [TBL] [Abstract][Full Text] [Related]
40. Haemagglutination-inhibiting antibody to influenza virus. de Jong JC; Palache AM; Beyer WE; Rimmelzwaan GF; Boon AC; Osterhaus AD Dev Biol (Basel); 2003; 115():63-73. PubMed ID: 15088777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]